L. Silverman

Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981–1995)

A. Moghrabi, B. Asselin, L. Clavell, 2000, Leukemia.

Minimal residual disease and outcome characteristics in infant KMT2A-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocol.

R. Pieters, V. V. D. van der Velden, M. Schrappe, 2021, European journal of cancer.